Insulin glargine and lixisenatide Subcutaneous and Thrombate III
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Thrombate III and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: antithrombin iii
Brand name: Thrombate III
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Thylox Acne Treatment Topical
- Insulin glargine and lixisenatide Subcutaneous-Thymoglobulin
- Insulin glargine and lixisenatide Subcutaneous-Thymoglobulin rabbit
- Insulin glargine and lixisenatide Subcutaneous-Thyrogen
- Insulin glargine and lixisenatide Subcutaneous-Thyroid
- Insulin glargine and lixisenatide Subcutaneous-Thyroid desiccated
- Thrombate III-Insulin glargine, recombinant Subcutaneous
- Thrombate III-Insulin glulisine
- Thrombate III-Insulin Glulisine (Cartridges and Pens)
- Thrombate III-Insulin Glulisine (Vials)
- Thrombate III-Insulin glulisine Subcutaneous
- Thrombate III-Insulin human inhaled Inhalation